CA
LLY icon

Chatterton & Associates’s Eli Lilly LLY Stock Holding History

Chatterton & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$714K Buy
587
+30
+5% +$30.7K 0.42% 45
2026
Q1 		$532K Buy
557
+69
+14% +$70K 0.37% 56
2025
Q4 		$524K Buy
+488
New +$467K 0.45% 49

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Chatterton & Associates's LLY Position: Q2 2026 in Review

Chatterton & Associates increased its Eli Lilly (LLY) stake by 5.4% in Q2 2026, buying an estimated $30.7K and bringing the position to 587 shares worth $714K. The position accounts for 0.42% of the portfolio, ranked #45.

Chatterton & Associates first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,861 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Chatterton & Associates held 587 shares of Eli Lilly worth $714K as of Q2 2026.
  • Chatterton & Associates bought 30 Eli Lilly shares in Q2 2026, an estimated $30.7K.
  • Eli Lilly made up 0.42% of Chatterton & Associates's portfolio in Q2 2026, its #45 holding.
  • Chatterton & Associates first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,861 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Chatterton & Associates's 13F filing for Q2 2026, filed 14 Jul 2026.